NXTC - NextCure, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5878.61M
Enterprise Value 3690.92M
Trailing P/E N/A
Forward P/E 1-19.54
PEG Ratio (5 yr expected) 1-0.55
Price/Sales (ttm)318.45
Price/Book (mrq)4.92
Enterprise Value/Revenue 3250.42
Enterprise Value/EBITDA 6-25.98

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 32.99%
52 Week High 344.69
52 Week Low 313.86
50-Day Moving Average 331.45
200-Day Moving Average 322.81

Share Statistics

Avg Vol (3 month) 371.8k
Avg Vol (10 day) 371.92k
Shares Outstanding 522.71M
Float 12.61M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Aug 15, 2019) 4236.79k
Short Ratio (Aug 15, 2019) 43.48
Short % of Float (Aug 15, 2019) 41.50%
Short % of Shares Outstanding (Aug 15, 2019) 41.04%
Shares Short (prior month Jul 15, 2019) 498.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,038.67%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.76M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -26.6M
Net Income Avi to Common (ttm)-26.95M
Diluted EPS (ttm)-1.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)192.69M
Total Cash Per Share (mrq)8.48
Total Debt (mrq)5M
Total Debt/Equity (mrq)2.80
Current Ratio (mrq)17.05
Book Value Per Share (mrq)7.86

Cash Flow Statement

Operating Cash Flow (ttm)67k
Levered Free Cash Flow (ttm)N/A